Question, has anyone here made a better recovery in 2023. Obviously the gains are good but has anyone out preformed me? - If you have I would love to know your strategy.


My strategy as been to do that thing we should never do a try and time the market. So ... See More far I’ve had nothing but wins.

What’s my ideal use case? (Concerns w/underage) - I’m underage and started paper trading in trading view, have considered the option of my parents making a custodial account, but I’m concerned about a few topics


Taxes and “cash out”:
I’m located in Mexico, and heard somewhere that indeed trading view is registered ... See More there for tax purposes, but I’m unsure of it, basically, will my parents have to do to the separate tax report, in case of a sell on a gain, or will it be included in my sell out?

Also, would I be able to use my debit card to buy/sell? (My debit card is for minors, but still has the capabilities of a regular card)
Or would it have to be my parent’s card?

Nvidia hard carrying my account fr

Fundamentals aside, NVDA is behaving as an AI ETF - While many AI startups are making waves in the industry, few have reached the stage of going public, leaving a void in the public markets for AI-focused investments. I think NVIDIA currently serves as a de facto investment vehicle for ... See More those bullish on AI, an effective proxy for AI growth, acting in essence as an AI ETF.

Which brings the question, why are new AI companies so shy on going public? In contrast with other "bubbles" (e.g dot-com) we are not seeing a lot of action. These companies could capture a lot of interest that now is funnelling to NVDA, MSFT and some other chip companies.

Why would Schwab report an average 10 day volume as “2.6B” ? - It’s for ticker AMC which had a reverse split today. Does the split have something to do with it? How can it be explained logically? It was in the tens of millions last night.

I don’t want ... See More to assume it’s “crime” or something shady so hopefully any logical answers? I can’t accept its just a random glitch. There’s way too many “glitches”.

I need to fill 560 characters to make this post but I think maybe there’s some merit to naked short selling against this company. Also with being on the New York Stock Exchanges FTD’s list for multiple weeks without any regulation or even acknowledgement from regulatory bodies speaks volumes. Welp, that should do it. Maybe one more sentence for good measure.

Nvidia continues AI-driven surge, announces $25B stock buyback

Is It Normal for a Medical Research Company Not To Show Its Research and Development Expenses? - A company’s gross margin has been in long-term decline. The average rate of decline per year is -4.6%. Of course, this is a cause for concern.

At the same time, its operating margin is ... See More expanding at the average rate of 3.1% per year, which is excellent. But its income statement doesn’t have a dedicated expense for R&D. When I tried to find out why its operating income is improving, I saw that “Other operating expense” had been declining at the average rate of 10.5% per year. This is good, unless R&D is hidden inside “Other operating expense”. I wonder if they are cutting down on their R&D, which may not be a good thing in the long run, considering it’s a medical research company.

So, in summary:

\- Gross margin is declining at a worrying rate.

\- Operating margin is expanding at a good rate.

\- There is no row in the income statement dedicated to ‘Research and Development”, even though this is a medical research company. I checked its peers, and they have a dedicated expense for “Research and Development”

\- “Other operating expense” is declining at a very good rate, which is a good thing.

\- But I don’t know if R&D spending is included in “Other operating expense”, which could mean they’re cutting their R&D spending, which could be detrimental to the long-term success of such a company, considering it’s a medical research company. \*

What do you think?